Evidence map›Paper›PMID 26597080›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Chloe Anthias, Bronwen E Shaw, Deidre M Kiefer, Jane L Liesveld, Jean Yared, Rammurti T Kamble, Anita D'Souza, Peiman Hematti, Matthew D Seftel, Maxim Norkin and 15 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Supportive Care of Hematopoietic Stem Cell Donors.Clinical hematology international · 2024
    Article
  5. Observational
  6. Experiences and unmet needs of family members requested to donate haematopoietic stem cells to an ill relative: findings from a prospective multi-centre study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 5 countries.

Chloe AnthiasAnthony Nolan Research Institute, London, UK. Electronic address: chloe.anthias@anthonynolan.org.
Bronwen E ShawDepartment of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Deidre M KieferCenter for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Jane L LiesveldDepartment of Medicine, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY, USA.
Jean YaredDepartment of Medicine, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Rammurti T KambleDivision of Hematology and Oncology, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX, USA.
Anita D'SouzaDepartment of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Peiman HemattiDivision of Hematology/Oncology/Bone Marrow Transplantation, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
Matthew D SeftelDepartment of Medical Oncology and Haematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
Maxim NorkinDivision of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Zachariah DeFilippWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Kimberly A KasowDivision of Hematology-Oncology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
Muneer H AbidiDepartment of Oncology, Spectrum Health, Michigan State University, Grand Rapids, MI, USA.
Bipin N SavaniDivision of Hematology/Oncology, Vanderbilt Medical Center, Nashville, TN, USA.
Nirali N ShahPediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Paolo AnderliniDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Miguel A DiazDepartment of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
Adriana K MaloneTisch Cancer Institute, Mount Sinai Medical Center, New York, NY, USA.
Joerg P HalterDepartment of Hematology, University Hospital Basel, Switzerland.
Hillard M LazarusSeidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Brent R LoganDepartment of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
Galen E SwitzerUniversity of Pittsburgh, VA Medical Healthcare System, Pittsburgh, PA, USA.
Michael A PulsipherDivision of Hematology, Oncology and Blood and Marrow Transplantation, Children's Hospital of Los Angeles, USC Keck School of Medicine, Los Angeles, CA, USA.
Dennis L ConferNational Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
Paul V O'DonnellFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Medical College of Wisconsin · USNational Marrow Donor Program · USAnthony Nolan · GBBaylor College of Medicine · USCancerCare Manitoba · CAChildren's Hospital of Los Angeles · USEmory University · USFred Hutch Cancer Center · USHospital Infantil Universitario Niño Jesús · ESMount Sinai Medical Center · USNational Cancer Institute · USSpectrum Health · USStrong Memorial Hospital · USThe University of Texas MD Anderson Cancer Center · USUniversity Hospital of Basel · CHUniversity Hospitals Cleveland Medical Center · USUniversity of Florida · USUniversity of Maryland, Baltimore · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
NCI NIH HHS U24 CA076518NCI NIH HHS U24-CA076518NHLBI NIH HHS 5U10HL069294NHLBI NIH HHS U10 HL069294PHS HHS HHSH250201200016C
6 · The paper itself

Abstract

Recent investigations have found a higher incidence of adverse events associated with hematopoietic cell donation in related donors (RDs) who have morbidities that if present in an unrelated donor (UD) would preclude donation. In the UD setting, regulatory standards ensure independent assessment of donors, one of several crucial measures to safeguard donor health and safety. A survey conducted by the Center for International Blood and Marrow Transplant Research (CIBMTR) Donor Health and Safety Working Committee in 2007 reported a potential conflict of interest in >70% of US centers, where physicians had simultaneous responsibility for RDs and their recipients. Consequently, several international organizations have endeavored to improve practice through regulations and consensus recommendations. We hypothesized that the changes in the 2012 Foundation for the Accreditation of Cellular Therapy and the Joint Accreditation Committee-International Society for Cellular Therapy and European Society for Blood and Marrow Transplantation standards resulting from the CIBMTR study would have significantly impacted practice. Accordingly, we conducted a follow-up survey of US transplantation centers to assess practice changes since 2007, and to investigate additional areas where RD care was predicted to differ from UD care. A total of 73 centers (53%), performing 79% of RD transplantations in the United States, responded. Significant improvements were observed since the earlier survey; 62% centers now ensure separation of RD and recipient care (P < .0001). This study identifies several areas where RD management does not meet international donor care standards, however. Particular concerns include counseling and assessment of donors before HLA typing, with 61% centers first disclosing donor HLA results to an individual other than the donor, the use of unlicensed mobilization agents, and the absence of long-term donor follow-up. Recommendations for improvement are made.

Indexed as

Tissue DonorsAdultFemaleGuideline AdherenceHospitals, SpecialHumansMalePractice Patterns, Physicians'Retrospective StudiesUnited StatesAccreditationHematopoietic cell donationRelated donor

Identifiers

PMID26597080
PMCPMC4760616
OpenAlexW2177488711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.